title: Enalapril-induced toxic pustuloderma.
abstract: Enalapril is widely prescribed for hypertension and cardiac failure. Rashes are an uncommon side-effect, occurring in approximately 1.4% of patients, and in approximately 0.4% of patients the rash is sufficient to require discontinuation of enalapril. (Merck Sharp and Dohme, pers. comm.) We report a case of toxic pustuloderma related to enalapril therapy for congestive cardiac failure. To our knowledge enalapril-induced toxic pustuloderma has not been previously reported.
authors.affiliation: University Department of Dermatology, Salford Royal Hospitals NHS Trust, Lancs, UK.
authors.forename: J E
authors.initials: JE
authors.lastname: Ferguson
authors.forename: R J
authors.initials: RJ
authors.lastname: Chalmers
mesh_terms: D000368:Aged; D000959:Antihypertensive Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D004656:Enalapril / Q000009:adverse effects*; D006801:Humans; D008297:Male; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced* / Q000473:pathology
chemical_list: D000959:Antihypertensive Agents; D004656:Enalapril